Axenic Long-Term Cultivation of Pneumocystis jirovecii

Diana Riebold1, Marie Mahnkopf1, Kristina Wicht2

  • 1Research Centre of Medical Technology and Biotechnology (FZMB), 99947 Bad Langensalza, Germany.

PubMed

Insights

Researchers successfully cultivated Pneumocystis jirovecii (PJP) in a lab setting for the first time. This breakthrough in PJP culture is crucial for understanding Pneumocystis pneumonia (PCP) and developing new treatments.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Microbiology

Background:

  • Pneumocystis jirovecii (PJP) causes severe Pneumocystis pneumonia (PCP) in humans.
  • PJP has historically been considered non-culturable, hindering research into PCP.
  • Existing studies on Pneumocystis species primarily involve animal models, with significant genotypic and phenotypic differences from PJP.

Purpose of the Study:

  • To develop the first successful axenic (cell-free) culture conditions for Pneumocystis jirovecii.
  • To establish a reliable method for cultivating PJP to facilitate research into PCP pathogenesis and treatment.

Main Methods:

  • Conducted a literature survey of animal-derived Pneumocystis culture methods.
  • Systematically trialed and optimized variables including incubation time, pH, vitamins, and amino acids.
  • Utilized quantitative PCR (qPCR) and microscopy to assess PJP growth and viability in the developed medium (DMEM-O3).

Main Results:

  • Achieved a 42.6-fold increase in PJP qPCR copy numbers after 48 days of culture.
  • Confirmed microscopic evidence of actively growing PJP clusters in the DMEM-O3 medium.
  • Determined the PJP doubling time to be approximately 8.9 days under the optimized conditions.

Conclusions:

  • Successfully established the first long-term axenic culture of Pneumocystis jirovecii.
  • The developed culture conditions represent a significant advancement for studying PJP and PCP.
  • Further optimization is necessary for this slow-growing fungus to fully elucidate its biology and clinical implications.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
262
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
314
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
353
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
157
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
253